Alkermes PLC (ALKS)
28.33
-0.91
(-3.11%)
USD |
NASDAQ |
Nov 14, 16:00
28.33
0.00 (0.00%)
After-Hours: 17:58
Alkermes Revenue (Quarterly): 378.14M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 378.14M |
| June 30, 2024 | 399.13M |
| March 31, 2024 | 350.37M |
| December 31, 2023 | 377.48M |
| September 30, 2023 | 380.94M |
| June 30, 2023 | 617.40M |
| March 31, 2023 | 287.60M |
| December 31, 2022 | 304.67M |
| September 30, 2022 | 252.36M |
| June 30, 2022 | 276.22M |
| March 31, 2022 | 278.54M |
| December 31, 2021 | 324.46M |
| September 30, 2021 | 294.14M |
| June 30, 2021 | 303.72M |
| March 31, 2021 | 251.43M |
| December 31, 2020 | 280.00M |
| September 30, 2020 | 265.01M |
| June 30, 2020 | 247.53M |
| March 31, 2020 | 246.22M |
| December 31, 2019 | 412.73M |
| September 30, 2019 | 255.24M |
| June 30, 2019 | 279.87M |
| March 31, 2019 | 223.10M |
| December 31, 2018 | 315.76M |
| September 30, 2018 | 248.72M |
| Date | Value |
|---|---|
| June 30, 2018 | 304.64M |
| March 31, 2018 | 225.15M |
| December 31, 2017 | 275.37M |
| September 30, 2017 | 217.38M |
| June 30, 2017 | 218.84M |
| March 31, 2017 | 191.78M |
| December 31, 2016 | 213.51M |
| September 30, 2016 | 180.24M |
| June 30, 2016 | 195.16M |
| March 31, 2016 | 156.77M |
| December 31, 2015 | 163.10M |
| September 30, 2015 | 152.65M |
| June 30, 2015 | 151.37M |
| March 31, 2015 | 161.21M |
| December 31, 2014 | 175.16M |
| September 30, 2014 | 159.99M |
| June 30, 2014 | 153.42M |
| March 31, 2014 | 130.21M |
| September 30, 2013 | 139.80M |
| June 30, 2013 | 138.63M |
| March 31, 2013 | 163.42M |
| December 31, 2012 | 135.91M |
| September 30, 2012 | 123.98M |
| June 30, 2012 | 152.24M |
| March 31, 2012 | 130.47M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
246.22M
Minimum
Mar 2020
617.40M
Maximum
Jun 2023
326.40M
Average
298.93M
Median
Revenue (Quarterly) Benchmarks
| Jazz Pharmaceuticals PLC | 1.055B |
| Medtronic PLC | 7.915B |
| Perrigo Co PLC | 1.088B |
| Iterum Therapeutics PLC | -- |
| Mallinckrodt PLC | 505.50M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 92.38M |
| Total Expenses (Quarterly) | 273.39M |
| EPS Diluted (Quarterly) | 0.55 |
| Enterprise Value | 4.111B |
| Gross Profit Margin (Quarterly) | 83.31% |
| Profit Margin (Quarterly) | 24.43% |
| Earnings Yield | 6.88% |
| Operating Earnings Yield | 6.51% |
| Normalized Earnings Yield | 8.048 |